A European-based company, MGC Pharmaceuticals specialises in medical cannabis. Their mission is to be an international pioneer in phytocannabinoid-based medicine within the biopharmaceutical industry.

Their founders are prominent leaders in the medical cannabis industry, with many years of practical, scientific, and business experience. As a company, their main business goal is the production and supply of high-quality cannabinoid based pharmaceutical products for emerging medical markets in Europe, North America, Australia, and Asia.

MGC Pharmaceuticals believes that phytomedicines can meet medical requirements and improve the lives of patients. As such, they collaborate with academia, prominent universities, global distributors, manufacturers, high-end consulting firms and companies worldwide to conduct research, creating the highest quality products for their patients. They also provide information and engagement to educate doctors on their research and development process as well as their clinical pipelines. Patients can also access the company’s patient portal which provides access to information on medical cannabis.

Products into three divisions – the Pharma Division focuses on medical products like nutraceuticals and extracts meant to supplement our bodies’ daily demands, while the Innovation division is focused on the treatment of neurological disorders, oncological care and treatment as well as autoimmune diseases.

Lastly, their Botanic Division works with multiple cultivation sites to meet product demand and conducts research into breeding and genetics with prolific institutions and academia.

MGC Pharmaceuticals has their European corporate headquarters in London, while their European operational headquarters are in Ljubljana, Slovenia. They also have a branch in Prague, but their corporate and financial headquarters are in Australia. They can be found at 1202, Hay Street, West Perth. For enquiries, send them an email at [email protected] or give them a call at +61 8 6382 3390.